APO Research

APO RESEARCH · REPORT

Asthma Reliever (Rescue) Medications

Selected research

Market Analysis & Forecast

Global Asthma Reliever (Rescue) Medications Market Analysis and Forecast 2026-2032

Market perspective

The global Asthma Reliever (Rescue) Medications market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Asthma Reliever (Rescue) Medications is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Asthma Reliever (Rescue) Medications is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Asthma Reliever (Rescue) Medications is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Asthma Reliever (Rescue) Medications is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Asthma Reliever (Rescue) Medications include AstraZeneca plc, Dulera, Genentech Inc, Glaxosmithkline plc, MAP Pharmaceuticals,Inc, Merck & Co. Inc, QVAR, Roche Holdings Ltd and Sanofi-Aventis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Asthma Reliever (Rescue) Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Asthma Reliever (Rescue) Medications, also provides the sales of main regions and countries. Of the upcoming market potential for Asthma Reliever (Rescue) Medications, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Asthma Reliever (Rescue) Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Asthma Reliever (Rescue) Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Asthma Reliever (Rescue) Medications sales, projected growth trends, production technology, application and end-user industry.

Asthma Reliever (Rescue) Medications Segment by Company

AstraZeneca plc

Dulera

Genentech Inc

Glaxosmithkline plc

MAP Pharmaceuticals,Inc

Merck & Co. Inc

QVAR

Roche Holdings Ltd

Sanofi-Aventis

Schering-Plough Corp

Sepracor, Inc

Theravance Inc

Asthma Reliever (Rescue) Medications Segment by Type

Quick-Relief Medications

Long-Term Control Medications

Asthma Reliever (Rescue) Medications Segment by Application

Adult

Children

Adolescent

Asthma Reliever (Rescue) Medications Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Reliever (Rescue) Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Reliever (Rescue) Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Reliever (Rescue) Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Asthma Reliever (Rescue) Medications in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Asthma Reliever (Rescue) Medications manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Asthma Reliever (Rescue) Medications sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Asthma Reliever (Rescue) Medications Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Quick-Relief Medications Major Manufacturers Table 3. Long-Term Control Medications Major Manufacturers Table 4. Global Asthma Reliever (Rescue) Medications Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Major Manufacturers Table 6. Children Major Manufacturers Table 7. Adolescent Major Manufacturers Table 8. Asthma Reliever (Rescue) Medications Industry Trends Table 9. Asthma Reliever (Rescue) Medications Industry Drivers Table 10. Asthma Reliever (Rescue) Medications Industry Opportunities and Challenges Table 11. Asthma Reliever (Rescue) Medications Industry Restraints Table 12. Global Asthma Reliever (Rescue) Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Asthma Reliever (Rescue) Medications Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Asthma Reliever (Rescue) Medications Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2021-2026) Table 16. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2027-2032) Table 17. Global Asthma Reliever (Rescue) Medications Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Asthma Reliever (Rescue) Medications Sales by Region (2021-2026) & (K Units) Table 19. Global Asthma Reliever (Rescue) Medications Sales by Region (2027-2032) & (K Units) Table 20. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2021-2026) Table 21. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2027-2032) Table 22. Global Asthma Reliever (Rescue) Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Asthma Reliever (Rescue) Medications Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Asthma Reliever (Rescue) Medications Sales Market Share by Manufacturers (2021-2026) Table 26. Global Asthma Reliever (Rescue) Medications Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Asthma Reliever (Rescue) Medications Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Asthma Reliever (Rescue) Medications Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Asthma Reliever (Rescue) Medications Manufacturers, Product Type & Application Table 30. Global Asthma Reliever (Rescue) Medications Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Asthma Reliever (Rescue) Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Asthma Reliever (Rescue) Medications Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Asthma Reliever (Rescue) Medications Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Asthma Reliever (Rescue) Medications Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2021-2026) Table 37. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2027-2032) Table 38. Global Asthma Reliever (Rescue) Medications Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Asthma Reliever (Rescue) Medications Sales by Type (2021-2026) & (K Units) Table 40. Global Asthma Reliever (Rescue) Medications Sales by Type (2027-2032) & (K Units) Table 41. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2021-2026) Table 42. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2027-2032) Table 43. Global Asthma Reliever (Rescue) Medications Price by Type (2021-2026) & (US$/Unit) Table 44. Global Asthma Reliever (Rescue) Medications Price by Type (2027-2032) & (US$/Unit) Table 45. Global Asthma Reliever (Rescue) Medications Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Asthma Reliever (Rescue) Medications Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Asthma Reliever (Rescue) Medications Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2021-2026) Table 49. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2027-2032) Table 50. Global Asthma Reliever (Rescue) Medications Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Asthma Reliever (Rescue) Medications Sales by Application (2021-2026) & (K Units) Table 52. Global Asthma Reliever (Rescue) Medications Sales by Application (2027-2032) & (K Units) Table 53. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2021-2026) Table 54. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2027-2032) Table 55. Global Asthma Reliever (Rescue) Medications Price by Application (2021-2026) & (US$/Unit) Table 56. Global Asthma Reliever (Rescue) Medications Price by Application (2027-2032) & (US$/Unit) Table 57. AstraZeneca plc Company Information Table 58. AstraZeneca plc Business Overview Table 59. AstraZeneca plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. AstraZeneca plc Asthma Reliever (Rescue) Medications Product Portfolio Table 61. AstraZeneca plc Recent Development Table 62. Dulera Company Information Table 63. Dulera Business Overview Table 64. Dulera Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Dulera Asthma Reliever (Rescue) Medications Product Portfolio Table 66. Dulera Recent Development Table 67. Genentech Inc Company Information Table 68. Genentech Inc Business Overview Table 69. Genentech Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Genentech Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 71. Genentech Inc Recent Development Table 72. Glaxosmithkline plc Company Information Table 73. Glaxosmithkline plc Business Overview Table 74. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Portfolio Table 76. Glaxosmithkline plc Recent Development Table 77. MAP Pharmaceuticals,Inc Company Information Table 78. MAP Pharmaceuticals,Inc Business Overview Table 79. MAP Pharmaceuticals,Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. MAP Pharmaceuticals,Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 81. MAP Pharmaceuticals,Inc Recent Development Table 82. Merck & Co. Inc Company Information Table 83. Merck & Co. Inc Business Overview Table 84. Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 86. Merck & Co. Inc Recent Development Table 87. QVAR Company Information Table 88. QVAR Business Overview Table 89. QVAR Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. QVAR Asthma Reliever (Rescue) Medications Product Portfolio Table 91. QVAR Recent Development Table 92. Roche Holdings Ltd Company Information Table 93. Roche Holdings Ltd Business Overview Table 94. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Portfolio Table 96. Roche Holdings Ltd Recent Development Table 97. Sanofi-Aventis Company Information Table 98. Sanofi-Aventis Business Overview Table 99. Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Portfolio Table 101. Sanofi-Aventis Recent Development Table 102. Schering-Plough Corp Company Information Table 103. Schering-Plough Corp Business Overview Table 104. Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Portfolio Table 106. Schering-Plough Corp Recent Development Table 107. Sepracor, Inc Company Information Table 108. Sepracor, Inc Business Overview Table 109. Sepracor, Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sepracor, Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 111. Sepracor, Inc Recent Development Table 112. Theravance Inc Company Information Table 113. Theravance Inc Business Overview Table 114. Theravance Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Theravance Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 116. Theravance Inc Recent Development Table 117. North America Asthma Reliever (Rescue) Medications Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Asthma Reliever (Rescue) Medications Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Asthma Reliever (Rescue) Medications Sales by Type (2021-2026) & (K Units) Table 120. North America Asthma Reliever (Rescue) Medications Sales by Type (2027-2032) & (K Units) Table 121. North America Asthma Reliever (Rescue) Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 122. North America Asthma Reliever (Rescue) Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 123. North America Asthma Reliever (Rescue) Medications Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Asthma Reliever (Rescue) Medications Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Asthma Reliever (Rescue) Medications Sales by Application (2021-2026) & (K Units) Table 126. North America Asthma Reliever (Rescue) Medications Sales by Application (2027-2032) & (K Units) Table 127. North America Asthma Reliever (Rescue) Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 128. North America Asthma Reliever (Rescue) Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 129. North America Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Asthma Reliever (Rescue) Medications Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 133. North America Asthma Reliever (Rescue) Medications Sales by Country (2021-2026) & (K Units) Table 134. North America Asthma Reliever (Rescue) Medications Sales by Country (2027-2032) & (K Units) Table 135. North America Asthma Reliever (Rescue) Medications Sales Price by Country (2021-2026) & (US$/Unit) Table 136. North America Asthma Reliever (Rescue) Medications Sales Price by Country (2027-2032) & (US$/Unit) Table 137. United States Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 138. Canada Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 139. Europe Asthma Reliever (Rescue) Medications Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe Asthma Reliever (Rescue) Medications Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe Asthma Reliever (Rescue) Medications Sales by Type (2021-2026) & (K Units) Table 142. Europe Asthma Reliever (Rescue) Medications Sales by Type (2027-2032) & (K Units) Table 143. Europe Asthma Reliever (Rescue) Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 144. Europe Asthma Reliever (Rescue) Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 145. Europe Asthma Reliever (Rescue) Medications Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Asthma Reliever (Rescue) Medications Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Asthma Reliever (Rescue) Medications Sales by Application (2021-2026) & (K Units) Table 148. Europe Asthma Reliever (Rescue) Medications Sales by Application (2027-2032) & (K Units) Table 149. Europe Asthma Reliever (Rescue) Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 150. Europe Asthma Reliever (Rescue) Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 151. Europe Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Europe Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Europe Asthma Reliever (Rescue) Medications Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 155. Europe Asthma Reliever (Rescue) Medications Sales by Country (2021-2026) & (K Units) Table 156. Europe Asthma Reliever (Rescue) Medications Sales by Country (2027-2032) & (K Units) Table 157. Europe Asthma Reliever (Rescue) Medications Sales Price by Country (2021-2026) & (US$/Unit) Table 158. Europe Asthma Reliever (Rescue) Medications Sales Price by Country (2027-2032) & (US$/Unit) Table 159. Germany Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 160. France Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 161. U.K. Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 162. Italy Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 163. Netherlands Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 164. China Asthma Reliever (Rescue) Medications Revenue by Type (2021-2026) & (US$ Million) Table 165. China Asthma Reliever (Rescue) Medications Revenue by Type (2027-2032) & (US$ Million) Table 166. China Asthma Reliever (Rescue) Medications Sales by Type (2021-2026) & (K Units) Table 167. China Asthma Reliever (Rescue) Medications Sales by Type (2027-2032) & (K Units) Table 168. China Asthma Reliever (Rescue) Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 169. China Asthma Reliever (Rescue) Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 170. China Asthma Reliever (Rescue) Medications Revenue by Application (2021-2026) & (US$ Million) Table 171. China Asthma Reliever (Rescue) Medications Revenue by Application (2027-2032) & (US$ Million) Table 172. China Asthma Reliever (Rescue) Medications Sales by Application (2021-2026) & (K Units) Table 173. China Asthma Reliever (Rescue) Medications Sales by Application (2027-2032) & (K Units) Table 174. China Asthma Reliever (Rescue) Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 175. China Asthma Reliever (Rescue) Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Asia Asthma Reliever (Rescue) Medications Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Asthma Reliever (Rescue) Medications Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Asthma Reliever (Rescue) Medications Sales by Type (2021-2026) & (K Units) Table 179. Asia Asthma Reliever (Rescue) Medications Sales by Type (2027-2032) & (K Units) Table 180. Asia Asthma Reliever (Rescue) Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 181. Asia Asthma Reliever (Rescue) Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 182. Asia Asthma Reliever (Rescue) Medications Revenue by Application (2021-2026) & (US$ Million) Table 183. Asia Asthma Reliever (Rescue) Medications Revenue by Application (2027-2032) & (US$ Million) Table 184. Asia Asthma Reliever (Rescue) Medications Sales by Application (2021-2026) & (K Units) Table 185. Asia Asthma Reliever (Rescue) Medications Sales by Application (2027-2032) & (K Units) Table 186. Asia Asthma Reliever (Rescue) Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 187. Asia Asthma Reliever (Rescue) Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 188. Asia Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Asia Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Asia Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Asia Asthma Reliever (Rescue) Medications Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 192. Asia Asthma Reliever (Rescue) Medications Sales by Country (2021-2026) & (K Units) Table 193. Asia Asthma Reliever (Rescue) Medications Sales by Country (2027-2032) & (K Units) Table 194. Asia Asthma Reliever (Rescue) Medications Sales Price by Country (2021-2026) & (US$/Unit) Table 195. Asia Asthma Reliever (Rescue) Medications Sales Price by Country (2027-2032) & (US$/Unit) Table 196. Japan Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 197. South Korea Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 198. India Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 199. Australia Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 200. China Taiwan Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 201. Southeast Asia Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 202. SAMEA Asthma Reliever (Rescue) Medications Revenue by Type (2021-2026) & (US$ Million) Table 203. SAMEA Asthma Reliever (Rescue) Medications Revenue by Type (2027-2032) & (US$ Million) Table 204. SAMEA Asthma Reliever (Rescue) Medications Sales by Type (2021-2026) & (K Units) Table 205. SAMEA Asthma Reliever (Rescue) Medications Sales by Type (2027-2032) & (K Units) Table 206. SAMEA Asthma Reliever (Rescue) Medications Sales Price by Type (2021-2026) & (US$/Unit) Table 207. SAMEA Asthma Reliever (Rescue) Medications Sales Price by Type (2027-2032) & (US$/Unit) Table 208. SAMEA Asthma Reliever (Rescue) Medications Revenue by Application (2021-2026) & (US$ Million) Table 209. SAMEA Asthma Reliever (Rescue) Medications Revenue by Application (2027-2032) & (US$ Million) Table 210. SAMEA Asthma Reliever (Rescue) Medications Sales by Application (2021-2026) & (K Units) Table 211. SAMEA Asthma Reliever (Rescue) Medications Sales by Application (2027-2032) & (K Units) Table 212. SAMEA Asthma Reliever (Rescue) Medications Sales Price by Application (2021-2026) & (US$/Unit) Table 213. SAMEA Asthma Reliever (Rescue) Medications Sales Price by Application (2027-2032) & (US$/Unit) Table 214. SAMEA Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. SAMEA Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. SAMEA Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. SAMEA Asthma Reliever (Rescue) Medications Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 218. SAMEA Asthma Reliever (Rescue) Medications Sales by Country (2021-2026) & (K Units) Table 219. SAMEA Asthma Reliever (Rescue) Medications Sales by Country (2027-2032) & (K Units) Table 220. SAMEA Asthma Reliever (Rescue) Medications Sales Price by Country (2021-2026) & (US$/Unit) Table 221. SAMEA Asthma Reliever (Rescue) Medications Sales Price by Country (2027-2032) & (US$/Unit) Table 222. Brazil Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 223. Argentina Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 224. Chile Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 225. Colombia Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 226. Peru Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 227. Saudi Arabia Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 228. Israel Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 229. UAE Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 230. Turkey Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 231. Iran Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 232. Egypt Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Asthma Reliever (Rescue) Medications Distributors List Table 236. Asthma Reliever (Rescue) Medications Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Asthma Reliever (Rescue) Medications Image Figure 2. Global Asthma Reliever (Rescue) Medications Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Reliever (Rescue) Medications Market Size Share 2021 VS 2025 VS 2032 Figure 4. Quick-Relief Medications Image Figure 5. Long-Term Control Medications Image Figure 6. Global Asthma Reliever (Rescue) Medications Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Asthma Reliever (Rescue) Medications Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Image Figure 9. Children Image Figure 10. Adolescent Image Figure 11. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Asthma Reliever (Rescue) Medications Revenue (2021-2032) & (US$ Million) Figure 13. Global Asthma Reliever (Rescue) Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2021-2032) Figure 16. Global Asthma Reliever (Rescue) Medications Sales (2021-2032) & (K Units) Figure 17. Global Asthma Reliever (Rescue) Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Asthma Reliever (Rescue) Medications Sales YoY (2021-2032) & (K Units) Figure 20. Europe Asthma Reliever (Rescue) Medications Sales YoY (2021-2032) & (K Units) Figure 21. China Asthma Reliever (Rescue) Medications Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Asthma Reliever (Rescue) Medications Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Asthma Reliever (Rescue) Medications Sales YoY (2021-2032) & (K Units) Figure 24. Global Asthma Reliever (Rescue) Medications Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Asthma Reliever (Rescue) Medications Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Asthma Reliever (Rescue) Medications Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2021-2032) Figure 30. Global Asthma Reliever (Rescue) Medications Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2021-2032) Figure 33. Global Asthma Reliever (Rescue) Medications Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2021-2032) Figure 36. Global Asthma Reliever (Rescue) Medications Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2021-2032) Figure 39. North America Asthma Reliever (Rescue) Medications Revenue Share by Type (2021-2032) Figure 40. North America Asthma Reliever (Rescue) Medications Sales Share by Type (2021-2032) Figure 41. North America Asthma Reliever (Rescue) Medications Revenue Share by Application (2021-2032) Figure 42. North America Asthma Reliever (Rescue) Medications Sales Share by Application (2021-2032) Figure 43. North America Asthma Reliever (Rescue) Medications Revenue Share by Country (2021-2032) Figure 44. North America Asthma Reliever (Rescue) Medications Sales Share by Country (2021-2032) Figure 45. Europe Asthma Reliever (Rescue) Medications Revenue Share by Type (2021-2032) Figure 46. Europe Asthma Reliever (Rescue) Medications Sales Share by Type (2021-2032) Figure 47. Europe Asthma Reliever (Rescue) Medications Revenue Share by Application (2021-2032) Figure 48. Europe Asthma Reliever (Rescue) Medications Sales Share by Application (2021-2032) Figure 49. Europe Asthma Reliever (Rescue) Medications Revenue Share by Country (2021-2032) Figure 50. Europe Asthma Reliever (Rescue) Medications Sales Share by Country (2021-2032) Figure 51. China Asthma Reliever (Rescue) Medications Revenue Share by Type (2021-2032) Figure 52. China Asthma Reliever (Rescue) Medications Sales Share by Type (2021-2032) Figure 53. China Asthma Reliever (Rescue) Medications Revenue Share by Application (2021-2032) Figure 54. China Asthma Reliever (Rescue) Medications Sales Share by Application (2021-2032) Figure 55. Asia Asthma Reliever (Rescue) Medications Revenue Share by Type (2021-2032) Figure 56. Asia Asthma Reliever (Rescue) Medications Sales Share by Type (2021-2032) Figure 57. Asia Asthma Reliever (Rescue) Medications Revenue Share by Application (2021-2032) Figure 58. Asia Asthma Reliever (Rescue) Medications Sales Share by Application (2021-2032) Figure 59. Asia Asthma Reliever (Rescue) Medications Revenue Share by Country (2021-2032) Figure 60. Asia Asthma Reliever (Rescue) Medications Sales Share by Country (2021-2032) Figure 61. SAMEA Asthma Reliever (Rescue) Medications Revenue Share by Type (2021-2032) Figure 62. SAMEA Asthma Reliever (Rescue) Medications Sales Share by Type (2021-2032) Figure 63. SAMEA Asthma Reliever (Rescue) Medications Revenue Share by Application (2021-2032) Figure 64. SAMEA Asthma Reliever (Rescue) Medications Sales Share by Application (2021-2032) Figure 65. SAMEA Asthma Reliever (Rescue) Medications Revenue Share by Country (2021-2032) Figure 66. SAMEA Asthma Reliever (Rescue) Medications Sales Share by Country (2021-2032) Figure 67. Asthma Reliever (Rescue) Medications Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Asthma Reliever (Rescue) Medications Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Quick-Relief Medications
  • Long-Term Control Medications
Applications
  • Adult
  • Children
  • Adolescent
Companies covered
  • AstraZeneca plc
  • Dulera
  • Genentech Inc
  • Glaxosmithkline plc
  • MAP Pharmaceuticals,Inc
  • Merck & Co. Inc
  • QVAR
  • Roche Holdings Ltd
  • Sanofi-Aventis
  • Schering-Plough Corp
  • Sepracor, Inc
  • Theravance Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Asthma Reliever (Rescue) Medications Market by Type
  3. 1.2.1 Global Asthma Reliever (Rescue) Medications Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Quick-Relief Medications
  5. 1.2.3 Long-Term Control Medications
  6. 1.3 Asthma Reliever (Rescue) Medications Market by Application
  7. 1.3.1 Global Asthma Reliever (Rescue) Medications Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult
  9. 1.3.3 Children
  10. 1.3.4 Adolescent
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Asthma Reliever (Rescue) Medications Market Dynamics
  1. 2.1 Asthma Reliever (Rescue) Medications Industry Trends
  2. 2.2 Asthma Reliever (Rescue) Medications Industry Drivers
  3. 2.3 Asthma Reliever (Rescue) Medications Industry Opportunities and Challenges
  4. 2.4 Asthma Reliever (Rescue) Medications Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Asthma Reliever (Rescue) Medications Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Asthma Reliever (Rescue) Medications Revenue by Region
  3. 3.2.1 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Asthma Reliever (Rescue) Medications Revenue by Region (2021-2026)
  5. 3.2.3 Global Asthma Reliever (Rescue) Medications Revenue by Region (2027-2032)
  6. 3.2.4 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Asthma Reliever (Rescue) Medications Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Asthma Reliever (Rescue) Medications Sales by Region
  9. 3.4.1 Global Asthma Reliever (Rescue) Medications Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Asthma Reliever (Rescue) Medications Sales by Region (2021-2026)
  11. 3.4.3 Global Asthma Reliever (Rescue) Medications Sales by Region (2027-2032)
  12. 3.4.4 Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Asthma Reliever (Rescue) Medications Revenue by Manufacturers
  2. 4.1.1 Global Asthma Reliever (Rescue) Medications Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Asthma Reliever (Rescue) Medications Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Asthma Reliever (Rescue) Medications Sales by Manufacturers
  6. 4.2.1 Global Asthma Reliever (Rescue) Medications Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Asthma Reliever (Rescue) Medications Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Asthma Reliever (Rescue) Medications Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Asthma Reliever (Rescue) Medications Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Asthma Reliever (Rescue) Medications Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Asthma Reliever (Rescue) Medications Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Asthma Reliever (Rescue) Medications Manufacturers, Product Type & Application
  13. 4.7 Global Asthma Reliever (Rescue) Medications Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Asthma Reliever (Rescue) Medications Market CR5 and HHI
  16. 4.8.2 2025 Asthma Reliever (Rescue) Medications Tier 1, Tier 2, and Tier 3
5 Asthma Reliever (Rescue) Medications Market by Type
  1. 5.1 Global Asthma Reliever (Rescue) Medications Revenue by Type
  2. 5.1.1 Global Asthma Reliever (Rescue) Medications Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Asthma Reliever (Rescue) Medications Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Asthma Reliever (Rescue) Medications Sales by Type
  6. 5.2.1 Global Asthma Reliever (Rescue) Medications Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Asthma Reliever (Rescue) Medications Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2021-2032)
  9. 5.3 Global Asthma Reliever (Rescue) Medications Price by Type
6 Asthma Reliever (Rescue) Medications Market by Application
  1. 6.1 Global Asthma Reliever (Rescue) Medications Revenue by Application
  2. 6.1.1 Global Asthma Reliever (Rescue) Medications Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Asthma Reliever (Rescue) Medications Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Asthma Reliever (Rescue) Medications Sales by Application
  6. 6.2.1 Global Asthma Reliever (Rescue) Medications Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Asthma Reliever (Rescue) Medications Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2021-2032)
  9. 6.3 Global Asthma Reliever (Rescue) Medications Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca plc
  2. 7.1.1 AstraZeneca plc Company Information
  3. 7.1.2 AstraZeneca plc Business Overview
  4. 7.1.3 AstraZeneca plc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca plc Asthma Reliever (Rescue) Medications Product Portfolio
  6. 7.1.5 AstraZeneca plc Recent Developments
  7. 7.2 Dulera
  8. 7.2.1 Dulera Company Information
  9. 7.2.2 Dulera Business Overview
  10. 7.2.3 Dulera Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Dulera Asthma Reliever (Rescue) Medications Product Portfolio
  12. 7.2.5 Dulera Recent Developments
  13. 7.3 Genentech Inc
  14. 7.3.1 Genentech Inc Company Information
  15. 7.3.2 Genentech Inc Business Overview
  16. 7.3.3 Genentech Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Genentech Inc Asthma Reliever (Rescue) Medications Product Portfolio
  18. 7.3.5 Genentech Inc Recent Developments
  19. 7.4 Glaxosmithkline plc
  20. 7.4.1 Glaxosmithkline plc Company Information
  21. 7.4.2 Glaxosmithkline plc Business Overview
  22. 7.4.3 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Portfolio
  24. 7.4.5 Glaxosmithkline plc Recent Developments
  25. 7.5 MAP Pharmaceuticals,Inc
  26. 7.5.1 MAP Pharmaceuticals,Inc Company Information
  27. 7.5.2 MAP Pharmaceuticals,Inc Business Overview
  28. 7.5.3 MAP Pharmaceuticals,Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 MAP Pharmaceuticals,Inc Asthma Reliever (Rescue) Medications Product Portfolio
  30. 7.5.5 MAP Pharmaceuticals,Inc Recent Developments
  31. 7.6 Merck & Co. Inc
  32. 7.6.1 Merck & Co. Inc Company Information
  33. 7.6.2 Merck & Co. Inc Business Overview
  34. 7.6.3 Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Portfolio
  36. 7.6.5 Merck & Co. Inc Recent Developments
  37. 7.7 QVAR
  38. 7.7.1 QVAR Company Information
  39. 7.7.2 QVAR Business Overview
  40. 7.7.3 QVAR Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 QVAR Asthma Reliever (Rescue) Medications Product Portfolio
  42. 7.7.5 QVAR Recent Developments
  43. 7.8 Roche Holdings Ltd
  44. 7.8.1 Roche Holdings Ltd Company Information
  45. 7.8.2 Roche Holdings Ltd Business Overview
  46. 7.8.3 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Portfolio
  48. 7.8.5 Roche Holdings Ltd Recent Developments
  49. 7.9 Sanofi-Aventis
  50. 7.9.1 Sanofi-Aventis Company Information
  51. 7.9.2 Sanofi-Aventis Business Overview
  52. 7.9.3 Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Portfolio
  54. 7.9.5 Sanofi-Aventis Recent Developments
  55. 7.10 Schering-Plough Corp
  56. 7.10.1 Schering-Plough Corp Company Information
  57. 7.10.2 Schering-Plough Corp Business Overview
  58. 7.10.3 Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Portfolio
  60. 7.10.5 Schering-Plough Corp Recent Developments
  61. 7.11 Sepracor, Inc
  62. 7.11.1 Sepracor, Inc Company Information
  63. 7.11.2 Sepracor, Inc Business Overview
  64. 7.11.3 Sepracor, Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sepracor, Inc Asthma Reliever (Rescue) Medications Product Portfolio
  66. 7.11.5 Sepracor, Inc Recent Developments
  67. 7.12 Theravance Inc
  68. 7.12.1 Theravance Inc Company Information
  69. 7.12.2 Theravance Inc Business Overview
  70. 7.12.3 Theravance Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Theravance Inc Asthma Reliever (Rescue) Medications Product Portfolio
  72. 7.12.5 Theravance Inc Recent Developments
8 North America
  1. 8.1 North America Asthma Reliever (Rescue) Medications Market Size by Type
  2. 8.1.1 North America Asthma Reliever (Rescue) Medications Revenue by Type (2021-2032)
  3. 8.1.2 North America Asthma Reliever (Rescue) Medications Sales by Type (2021-2032)
  4. 8.1.3 North America Asthma Reliever (Rescue) Medications Price by Type (2021-2032)
  5. 8.2 North America Asthma Reliever (Rescue) Medications Market Size by Application
  6. 8.2.1 North America Asthma Reliever (Rescue) Medications Revenue by Application (2021-2032)
  7. 8.2.2 North America Asthma Reliever (Rescue) Medications Sales by Application (2021-2032)
  8. 8.2.3 North America Asthma Reliever (Rescue) Medications Price by Application (2021-2032)
  9. 8.3 North America Asthma Reliever (Rescue) Medications Market Size by Country
  10. 8.3.1 North America Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Asthma Reliever (Rescue) Medications Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Asthma Reliever (Rescue) Medications Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Asthma Reliever (Rescue) Medications Market Size by Type
  2. 9.1.1 Europe Asthma Reliever (Rescue) Medications Revenue by Type (2021-2032)
  3. 9.1.2 Europe Asthma Reliever (Rescue) Medications Sales by Type (2021-2032)
  4. 9.1.3 Europe Asthma Reliever (Rescue) Medications Price by Type (2021-2032)
  5. 9.2 Europe Asthma Reliever (Rescue) Medications Market Size by Application
  6. 9.2.1 Europe Asthma Reliever (Rescue) Medications Revenue by Application (2021-2032)
  7. 9.2.2 Europe Asthma Reliever (Rescue) Medications Sales by Application (2021-2032)
  8. 9.2.3 Europe Asthma Reliever (Rescue) Medications Price by Application (2021-2032)
  9. 9.3 Europe Asthma Reliever (Rescue) Medications Market Size by Country
  10. 9.3.1 Europe Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Asthma Reliever (Rescue) Medications Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Asthma Reliever (Rescue) Medications Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Asthma Reliever (Rescue) Medications Market Size by Type
  2. 10.1.1 China Asthma Reliever (Rescue) Medications Revenue by Type (2021-2032)
  3. 10.1.2 China Asthma Reliever (Rescue) Medications Sales by Type (2021-2032)
  4. 10.1.3 China Asthma Reliever (Rescue) Medications Price by Type (2021-2032)
  5. 10.2 China Asthma Reliever (Rescue) Medications Market Size by Application
  6. 10.2.1 China Asthma Reliever (Rescue) Medications Revenue by Application (2021-2032)
  7. 10.2.2 China Asthma Reliever (Rescue) Medications Sales by Application (2021-2032)
  8. 10.2.3 China Asthma Reliever (Rescue) Medications Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Asthma Reliever (Rescue) Medications Market Size by Type
  2. 11.1.1 Asia Asthma Reliever (Rescue) Medications Revenue by Type (2021-2032)
  3. 11.1.2 Asia Asthma Reliever (Rescue) Medications Sales by Type (2021-2032)
  4. 11.1.3 Asia Asthma Reliever (Rescue) Medications Price by Type (2021-2032)
  5. 11.2 Asia Asthma Reliever (Rescue) Medications Market Size by Application
  6. 11.2.1 Asia Asthma Reliever (Rescue) Medications Revenue by Application (2021-2032)
  7. 11.2.2 Asia Asthma Reliever (Rescue) Medications Sales by Application (2021-2032)
  8. 11.2.3 Asia Asthma Reliever (Rescue) Medications Price by Application (2021-2032)
  9. 11.3 Asia Asthma Reliever (Rescue) Medications Market Size by Country
  10. 11.3.1 Asia Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Asthma Reliever (Rescue) Medications Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Asthma Reliever (Rescue) Medications Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Asthma Reliever (Rescue) Medications Market Size by Type
  2. 12.1.1 SAMEA Asthma Reliever (Rescue) Medications Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Asthma Reliever (Rescue) Medications Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Asthma Reliever (Rescue) Medications Price by Type (2021-2032)
  5. 12.2 SAMEA Asthma Reliever (Rescue) Medications Market Size by Application
  6. 12.2.1 SAMEA Asthma Reliever (Rescue) Medications Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Asthma Reliever (Rescue) Medications Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Asthma Reliever (Rescue) Medications Price by Application (2021-2032)
  9. 12.3 SAMEA Asthma Reliever (Rescue) Medications Market Size by Country
  10. 12.3.1 SAMEA Asthma Reliever (Rescue) Medications Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Asthma Reliever (Rescue) Medications Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Asthma Reliever (Rescue) Medications Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Asthma Reliever (Rescue) Medications Value Chain Analysis
  2. 13.1.1 Asthma Reliever (Rescue) Medications Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Asthma Reliever (Rescue) Medications Production Mode & Process
  6. 13.2 Asthma Reliever (Rescue) Medications Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Asthma Reliever (Rescue) Medications Distributors
  9. 13.2.3 Asthma Reliever (Rescue) Medications Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research